Skip to main content
Premium Trial:

Request an Annual Quote

Adaptive Biotechnologies T-Detect Lyme

Adaptive Biotechnologies has launched T-Detect Lyme, the second product in the company’s growing T-Detect immune testing franchise. Administered as a blood test, T-Detect Lyme identifies T cells activated by Borrelia burgdorferi, the bacterium that causes Lyme disease, to help diagnose early disease, the company said. The test is designed for adult patients demonstrating signs and symptoms including but not limited to the presence of an erythema migrans rash, fever, chills, headache, fatigue, muscle and joint aches, and swollen lymph nodes, according to the company. Adaptive said T-Detect Lyme is available to patients with a prescription through a qualified healthcare professional as a CLIA laboratory-developed test service.

The Scan

Nature Papers on Long Reads for Bacterial Genomes, Zebrafish Atlas, Hypothalamic Aging in Mammals

In Nature this week: near-finished microbial genomes without polishing, zebrafish functional annotation program, and more. 

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.